No Detail Found!

Formulation development and pharmacokinetic evaluation of celecoxib loaded hydroxyl propyl methyl cellulose (HPMC) microparticles in in- vivo model

Author(s)
Khuram Shahazad Faculty of Pharmacy and Health Sciences, University of Balochistan,Quetta.,Pakistan
Syed Umer Jan Faculty of Pharmacy and Health Sciences, University of Balochistan,Quetta.,Pakistan
Rahman Gul Faculty of Pharmacy and Health Sciences, University of Balochistan,Quetta.,Pakistan
Mahjabeen Tafazzul Department of Botany, University of Balochistan,Quetta.,Pakistan
Safia Mengal Institute of Public Health,Quetta.,Pakistan
Falsafa Jamal Community Medicine Department, Bolan Medical College,Quetta. Balochistan.,Pakistan
Nayab Iqbal Faculty of Pharmacy and Health Sciences, University of Balochistan,Quetta.,Pakistan
Abstract
This investigation aimed to formulate Celecoxib-loaded microparticles for targeted delivery to the colon, employing Hydroxypropylmethylcellulose (HPMC). Celecoxib's effectiveness in managing colorectal cancer (CRC)related pain and inflammation is compromised by its low solubility and gastrointestinal side effects. A total of seventeen formulations were synthesized through emulsion solvent evaporation (ESE) oil-in-oil technique. The physicochemical properties of the formulations were analyzed through Fourier Transform Infrared Spectroscopy, X-ray Diffraction, Scanning Electron Microscopy and Differential Scanning Calorimetry; however, rabbits served as the biological specimens in the in vivo pharmacokinetic evaluation in Rabbits plasma. Celecoxib pure drug, F1 and F2 were given to the rabbits one time dose to assess the pharmacokinetics evaluation. The average particle size for F 1 was 497.93µm and 497.93 µm for F 2. In vitro showed cumulative release rates of 88.77% for F1 and 88.85% F2 after 24 hours. FTIR analysis confirmed the compatibility of the formulation ingredients, XRD revealed a transition of Celecoxib from its crystalline to amorphous form, DSC indicated the formulations' thermal stability and SEM images showed dense, spherical microparticles. Given these factors, using HPMC micro particles to carry Celecoxib could enhance the drug delivery and released in the body and may result effective treatment with fewer side effects.
Publication Details
Page(s) 1470-1483
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 4, Year: 2025

Request the full text from PASTIC

Keywords
microparticles, HPMC, HPLC, Celecoxib, pharmacokinetic study
References
Abadi SSH,Gangadharappa H,Balamuralidhara VJ. .2020 .Development of colon-specific mucoadhesive meloxicam microspheres for the treatment of CFA induced arthritis in rats. Int. J. Polyme. Mate. Polyme. Biomater, 70(12) : 849-869.
Alvi Z,Akhtar M,Rahman NU,Hosny KM,Sindi AM,Khan BA,Nazir I,Sadaquat H I .2021 .Utilization of gelling polymer to formulate nanoparticles loaded with epalrestat-cyclodextrin inclusion complex: Formulation, characterization, in-silico modelling and in-vivo toxicity Evaluation. , 13(24) : 4350.
Anwar S,Jan SU,Gul R .2020 .Formulation and evaluation of celecoxib cream and its released study. Int. J. Curr. Pharm. Res., (5): 10.22159, : .
Bae JW,Kim MJ,Jang CG,Lee SY .2007 .Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study. J. Chromatograp. B., 859(1) : 69-73.
Chawla G,Gupta P,Thilagavathi R,Chakraborti AK,Bansal AK .2003 .Characterization of solid-state forms of celecoxib. Eur. J. Pharm. Sci., 20(3) : 305-317.
Chowdary KPR,Sekuboyina VS .2006 .Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl β-cyclodextrin. AAPS Pharm. Sci. Tech, 7(3) : E184-89.
Chaudhari VS,Borkar RM,Murty US,Banerjee S US .2020 .Analytical method development and validation of reverse-phase high-performance liquid chromatography (RP-HPLC) method for simultaneous quantifications of quercetin and piperine in dual-drug loaded nanostructured lipid carriers. J. Pharmaceu. Biomed. Analy., 186 : 113325.
Ford J .1999 .Thermal Analysis of Hydroxypropylmethylcellulose and Methylcellulose: Powders, gels and matrix tablets. Int. J. Pharmaceu., 179(2) : 209-228.
Eun-Sol Ha,Hee-Young Jeong,Gwang-Ho Choo,Young-Suk Jung,Jeong-Soo Kim,Sung-Joo Hwang Kim,Min-Soo Kim Kim .2015 .Fabrication and evaluation of celecoxib microparticle surface modified by hydrophilic cellulose and surfactant. Int. J. Biolo. Macromole., 72 : 1473-1478.
Gul R,Jan SU,Ahmad M,Akhtar M,Qureshi MM .2019 .Formulation, characterization and in vivo evaluation of hedera helix l., topical dosage forms. Pak. J. Pharm. Sci., 32(6) : 2605-2610.
Hamid HA,Khan S,Noor Shah SM,Asghar M,Shahid M,Hussain Z,Sohail M,Khan BA,Amin F,Jan SU,Elhissi A,Shah SMH,Minhas MU,Shah SWA,Ahmad N SWA .2021 .Piroxicam loaded polymer hybrid microspheresbased tablets with modified release kinetics: Development, characterization and in vivo evaluation. Pak. J. Pharm. Sci., 34(1 Supplementary)) : 327-335.
Hnatyszyn A,Hryhorowicz S,Kaczmarek-Ryś M,Lis E,Słomski R,Scott RJ,Pławski A .2019 .Colorectal carcinoma in the course of inflammatory bowel diseases. Hered. Cancer Clin. Pract, 17(1) : 1-9.
Kashif PM,Madni A,Ashfaq M,Rehman M,Mahmood MA,Khan MI,Tahir N MI .2017 .Development of Eudragit RS 100 microparticles loaded with ropinirole: Optimization and in vitro evaluation Studies. AAPS Pharm. Sci. Tech, 18(5) : 1810-1822.
Katona G,Balogh GT,Dargo G,Gáspár R,Márki Á,Ducza E,Sztojkov-Ivanov A,Tomosi F,Kecskeméti G,Janáky T .2020 .Development of meloxicam human serum albumin nanoparticles for nose-to-brain delivery via application of a quality by design approach. J. Pharmaceutics, 12(2) : 97.
Krier F,Brion M,Debrus B,Lebrun P,Driesen A,Ziemons E,Evrard B,Hubert P .2011 .Optimisation and validation of a fast HPLC method for the quantification of sulindac and its related impurities. J. Pharmaceut. Biomed. Analy., 54(4) : 694-700.
Lu GW,Hawley M,Smith M,Geiger BM,Pfund W .2006 .Characterization of a novel polymorphic form of celecoxib. J. Pharma. Sci., 95(2) : 305-317.
Maqbool I,Akhtar M,Ahmad R,Sadaquat H,Noreen S,Batool A,Khan SU .2020 .Novel multiparticulate pH triggered delayed release chronotherapeutic drug delivery of celecoxib-β-cyclodextrin inclusion complexes by using Box-Behnken design. Eur. J. Pharm. Sci., 15 : 105254.
Nasr AM,Elhady SS,Swidan SA,Badawi NM .2020 .Celecoxib loaded in-situ provesicular powder and its invitro cytotoxic effect for cancer therapy: Fabrication, characterization, optimization and pharmacokinetic evaluation. Pharmaceu, 12(12) : 1157.
Wasay SA,Jan SU,Akhtar M,Noreen S,Gul R .2022 .Developed meloxicam loaded microparticles for colon targeted delivery: Statistical optimization, physicochemical characterization and in-vivo toxicity study. PLoS One, 17(4) : e0267306.
Patel MM .2017 .Formulation and development of didependent microparticulate system for colon-specific drug delivery. Drug deliv. and trans. res., 7(2) : 312-324.
Q8 I .2005 .ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use. Topic Q9: Quality Risk Management Geneva. , : .
Rowe RC,Sheskey PJ,Owen SC .2006 .Handbook of Pharmaceutical Excipients. , : 278-560.
Salunkhe NH,Jadhav NR,Bhinge SD .2018 .Validated RP-HPLC method for quantification of felodipine in rabbit plasma: Application in a bioequivalence study. , 77(1) : 15-19.
Sharma M,Kohli S,Dinda A .2015 .In-vitro and in vivo evaluation of repaglinide loaded floating microspheres prepared from different viscosity grades of HPMC polymer. , 23(6) : 675-682.
Vijayakumar B,Kannappan V,Sathyanarayana V,Mole V .2016 .DFT analysis and spectral characteristics of Celecoxib a potent COX-2 inhibitor. , 1121 : 16-25.
Wasay SA,Jan SU,Akhtar M,Rabbiya A,Shah PA,Razaque G,Muhammad S,Shahwani NA,Younis M,Achakzai JK .2022 .Meloxicam loaded hydroxypropyl methylcellulose (HPMC) microparticulate: Fabrication, characterization and in vivo pharmacokinetic assessment. Pak. J. Pharm. Sci., 35 : 1251-1260.
Xi Y,Xu P Y .2021 .Global colorectal cancer burden in 2020 and projections to 2040. , 14(10) : 101174.
Ziaei E,Emami J,Kazemi M,Rezazadeh M M .2020 .Simultaneous determination of docetaxel and celecoxib in porous microparticles and rat plasma by liquid-liquid extraction and HPLC with UV detection: In vitro and in vivo validation and application. J. Pharm. Pharm. Sci., 23 : 289-303.
0

Citations

0

Downloads

116

Views